1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine

C17H37BBrNO2Si2 — CID 20700923

IUPAC1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine
SMILESCC1CC(C)C2(C)OB(C(CBr)N([Si](C)(C)C)[Si](C)(C)C)OC2C1
InChIInChI=1S/C17H37BBrNO2Si2/c1-13-10-14(2)17(3)15(11-13)21-18(22-17)16(12-19)20(23(4,5)6)24(7,8)9/h13-16H,10-12H2,1-9H3
InChIKeyKFAXYHOVFSHYLZ-UHFFFAOYSA-N
MW434.38 g/mol
LogP4.99
Rot. Bonds5

About 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine

1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine (PubChem CID 20700923) has the molecular formula C17H37BBrNO2Si2 and a molecular weight of 434.38 g/mol. Its IUPAC name is 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine.

Molecular Properties

Compound Name1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine
PubChem CID20700923
Molecular FormulaC17H37BBrNO2Si2
Molecular Weight434.38 g/mol
Exact Mass433.16
IUPAC Name1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine
SMILESCC1CC(C)C2(C)OB(C(CBr)N([Si](C)(C)C)[Si](C)(C)C)OC2C1
InChIInChI=1S/C17H37BBrNO2Si2/c1-13-10-14(2)17(3)15(11-13)21-18(22-17)16(12-19)20(23(4,5)6)24(7,8)9/h13-16H,10-12H2,1-9H3
InChIKeyKFAXYHOVFSHYLZ-UHFFFAOYSA-N
XLogP4.99
TPSA21.70 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500434.38
LogP ≤ 54.99
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine?
The IUPAC name of 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine (CID 20700923) is 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine.
What is the SMILES notation for 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine?
The canonical SMILES for 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine is CC1CC(C)C2(C)OB(C(CBr)N([Si](C)(C)C)[Si](C)(C)C)OC2C1.
What is the InChIKey of 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine?
The InChIKey is KFAXYHOVFSHYLZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H37BBrNO2Si2/c1-13-10-14(2)17(3)15(11-13)21-18(22-17)16(12-19)20(23(4,5)6)24(7,8)9/h13-16H,10-12H2,1-9H3.
What are the key properties of 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine?
1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine has a molecular weight of 434.38 g/mol, XLogP of 4.99, 5 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(5,7,7a-trimethyl-4,5,6,7-tetrahydro-3aH-benzo[d][1,3,2]dioxaborol-2-yl)-2-bromo-N,N-bis(trimethylsilyl)ethanamine is sourced from PubChem (CID 20700923), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).